Literature DB >> 2154334

Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene.

E A Rose1, T Glaser, C Jones, C L Smith, W H Lewis, K M Call, M Minden, E Champagne, L Bonetta, H Yeger.   

Abstract

A complete physical map of the 11p13 region containing the Wilms' tumor locus has been developed and used to localize a candidate Wilms' tumor gene. Our strategy to construct the map combined the use of pulsed-field gel electrophoresis and irradiation-reduced somatic cell hybrids. These hybrids, which contain limited segments of human chromosome 11 segregated from the remainder of the human genome, permit direct visualization of restriction fragments located in 11p13 using human interspersed repeated DNA sequences as hybridization probes. The physical map has provided a framework to identify the sites of genes responsible for the complex of disorders associated with hemizygous 11p13 deletion: Wilms' tumor, aniridia, genitourinary abnormalities, and mental retardation. The Wilms' tumor locus has been limited to a region of less than 345 kb, and a transcript with many of the characteristics expected for the Wilms' tumor gene has been localized to this region.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154334     DOI: 10.1016/0092-8674(90)90600-j

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  54 in total

1.  Characterization of the central region containing the X-inactivation center and terminal region of the mouse X chromosome using irradiation and fusion gene transfer hybrids.

Authors:  L Sefton; D Arnaud; P N Goodfellow; M C Simmler; P Avner
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 2.  Educational paper: the podocytopathies.

Authors:  Anja K Büscher; Stefanie Weber
Journal:  Eur J Pediatr       Date:  2012-01-13       Impact factor: 3.183

Review 3.  Evaluation of current cancer immunotherapy: hemato-oncology.

Authors:  Christopher S Hourigan; Hyam I Levitsky
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

Review 4.  Neonatal tumours.

Authors:  Kokila Lakhoo; Helen Sowerbutts
Journal:  Pediatr Surg Int       Date:  2010-10-19       Impact factor: 1.827

Review 5.  Long-range walking techniques in positional cloning strategies.

Authors:  L Stubbs
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 6.  Tumor suppressor genes: a new era for molecular genetic studies of cancer.

Authors:  E Y Lee
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

Review 7.  Mouse chromosome 2.

Authors:  L D Siracusa; C M Abbott
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

8.  Variation in genomic Alu repeat density as a basis for rapid construction of low resolution physical maps of human chromosomes.

Authors:  M J Lane; P G Waterbury; W T Carroll; A M Smardon; B D Faldasz; S M Peshick; S Mante; C S Huckaby; R E Kouri; D J Hanlon
Journal:  Chromosoma       Date:  1992-03       Impact factor: 4.316

9.  Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.

Authors:  Anja Lehnhardt; Claartje Karnatz; Thurid Ahlenstiel-Grunow; Kerstin Benz; Marcus R Benz; Klemens Budde; Anja K Büscher; Thomas Fehr; Markus Feldkötter; Norbert Graf; Britta Höcker; Therese Jungraithmayr; Günter Klaus; Birgit Koehler; Martin Konrad; Birgitta Kranz; Carmen R Montoya; Dominik Müller; Thomas J Neuhaus; Jun Oh; Lars Pape; Martin Pohl; Brigitte Royer-Pokora; Uwe Querfeld; Reinhard Schneppenheim; Hagen Staude; Giuseppina Spartà; Kirsten Timmermann; Frauke Wilkening; Simone Wygoda; Carsten Bergmann; Markus J Kemper
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-27       Impact factor: 8.237

10.  Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus.

Authors:  Reyhan El-Kares; Pierre-Alain Hueber; Miriam Blumenkrantz; Diana Iglesias; Kim Ma; Nada Jabado; Daniel G Bichet; Paul Goodyer
Journal:  Pediatr Nephrol       Date:  2009-03-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.